DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER

« Back to Dashboard

Clinical Trials for Theophylline 0.04% And Dextrose 5% In Plastic Container

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000575	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	CAMP Steering Committee	Phase 3	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	Johns Hopkins Bloomberg School of Public Health	Phase 3	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.

Clinical Trial Conditions for Theophylline 0.04% And Dextrose 5% In Plastic Container

Condition Name

Condition Name for Theophylline 0.04% And Dextrose 5% In Plastic Container
Intervention	Trials
Asthma	18
Chronic Obstructive Pulmonary Disease	8
COPD	7

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Theophylline 0.04% And Dextrose 5% In Plastic Container
Intervention	Trials
Lung Diseases	18
Pulmonary Disease, Chronic Obstructive	15
Asthma	13

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Theophylline 0.04% And Dextrose 5% In Plastic Container

Trials by Country

Trials by Country for Theophylline 0.04% And Dextrose 5% In Plastic Container
Location	Trials
United States	96
China	24
United Kingdom	11
Canada	9
Spain	6

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Theophylline 0.04% And Dextrose 5% In Plastic Container
Location	Trials
California	9
Colorado	8
Texas	6
Wisconsin	5
North Carolina	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Theophylline 0.04% And Dextrose 5% In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Theophylline 0.04% And Dextrose 5% In Plastic Container
Clinical Trial Phase	Trials
Phase 4	16
Phase 3	16
Phase 2/Phase 3	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Theophylline 0.04% And Dextrose 5% In Plastic Container
Clinical Trial Phase	Trials
Completed	55
Unknown status	8
Recruiting	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Theophylline 0.04% And Dextrose 5% In Plastic Container

Sponsor Name

Sponsor Name for Theophylline 0.04% And Dextrose 5% In Plastic Container
Sponsor	Trials
National Heart, Lung, and Blood Institute (NHLBI)	8
Boehringer Ingelheim	4
The First Affiliated Hospital of Guangzhou Medical University	4

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Theophylline 0.04% And Dextrose 5% In Plastic Container
Sponsor	Trials
Other	83
Industry	26
NIH	11

Export unavailable in trial.
Subscribe for complete access.